Search For "covaxin"
'Portrays incorrect picture', MEA on reports of it asking Bharat Biotech t
Updated : 3 years, 11 months ago IST
New Delhi [India], April 29 (ANI): The Minstry of External Affairs has said that media reports purportedly quoting a communication from the ministry asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval (EUA) nod for its COVID jab, "potra
Read More
India's expanding COVID-19 vaccination programme set to achieve new milest
Updated : 3 years, 11 months ago IST
New Delhi [India], April 27 (ANI): India has vaccinated over 96 per cent of its adult population with at least one dose of the COVID-19 vaccine and about 84 per cent of people above 15 years of age have received both the doses.
Read More
Paediatricians welcome COVID vaccines for kids, say parents mustn't hesita
Updated : 3 years, 11 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
Updated : 3 years, 11 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group.
Read More
Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for
Updated : 3 years, 11 months ago IST
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.
Read More
Expert panel of DCGI holds meet to discuss recommendations to use COVID-19
Updated : 3 years, 11 months ago IST
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged
Read More
Ocugen to commercialize Covaxin in Mexico, rights now encompassing all of
Updated : 3 years, 11 months ago IST
Malvern (Pennsylvania) [US]/ Hyderabad (Telangana) [India], April 18 (ANI): Biotechnology company Ocugen and Bharat Biotech (BBIL), on Monday, announced that they have entered into an amendment to their Co-development, Supply and Commercialization Agreement to expand Ocugen's exclusive terri
Read More
Indian COVID vaccines better than Pfizer, Moderna says Adar Poonawalla
Updated : 3 years, 11 months ago IST
New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
Read More
COVID vaccine: Covaxin price reduced from Rs 1,200 to Rs 225 per dose for
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 9 (ANI): Welcoming the decision to make precautionary dose available for all adults, Hyderabad-based vaccine manufacturer Bharat Biotech on Saturday, announced that it has revised the price of its COVID vaccine Covaxin from Rs 1,200 to Rs 225 per dose for
Read More
Covaxin supply suspension by WHO not to impact travel by people: MEA
Updated : 3 years, 11 months ago IST
New Delhi [India], April 8 (ANI): World Health Organization (WHO) suspending the supply of Covaxin through UN procurement agencies over "process and facility upgrade" requirements will not have an impact on travel by those who have taken the COVID vaccine, Ministry of External Affairs said o
Read More
Japan recognizes India's COVAXIN to facilitate travel between both countri
Updated : 3 years, 11 months ago IST
Tokyo [Japan], April 7 (ANI): Japan recognizes India's COVID-19 vaccine COVAXIN manufactured by Bharat Biotech with effect from April 10 to further facilitate travel from India to Japan, said the Indian Embassy in Japan on Thursday.
Read More